
Imricor (ASX: IMR) Expands U.S. Market with FDA Pediatric Clearance for NorthStar System
Imricor (ASX: IMR) expands its U.S. market after FDA pediatric clearance for the NorthStar Mapping System and Vision-MR Diagnostic Catheter, opening access to more than 250 children’s hospitals.






















%252520Is%252520a%252520Stock%252520to%252520Watch%252520What%2525E2%252580%252599s%252520Powering%252520the%252520Recent%252520Market%252520Buzz.webp&w=3840&q=75)






.png&w=3840&q=75)













%252520Receives%252520Takeover%252520Proposal%252520from%252520U.S.%252520Antimony%252520Corporation%252520(NYSE%252520UAMY).webp&w=3840&q=75)






















.webp&w=3840&q=75)


%252520%252520Rallies%25252027%252520percent%252520on%252520Symvess%252520Momentum%252520and%252520Insider%252520Optimism%252520Is%252520the%252520Tide%252520Turning.webp&w=3840&q=75)
%252520Is%252520Emerging%252520as%252520a%252520Cybersecurity%252520Stock%252520to%252520Watch.webp&w=3840&q=75)

%252520Stock%252520Soars%252520153%252520%252520on%252520Record%252520Growth%252520%2526%252520Expanding%252520US%252520Business.webp&w=3840&q=75)